Yahoo Finance's Tom Belger has the latest from London.
Yahoo Finance's Tom Belger has the latest from London.
Luggage deals for Black Friday, including wheeled backpacks, carry-ons & luggage set discounts
(Bloomberg) -- A sharp rebound in global equities after the Federal Reserve’s unprecedented stimulus in March has spurred the biggest shift in Japanese fund flows in seven years.The Asian nation’s investors sold 3.91 trillion yen ($37.4 billion) of foreign shares in the six months ended Sept. 30, the latest balance-of-payments data showed, the most since 2013. They bought 11.8 trillion yen of local sovereign debt, also the biggest amount in seven years, according to figures from the Japan Securities Dealers Association.The pivot reflects the twin themes of worries over a virus-devastated world economy and the prevalence of the 60/40 stocks-bond portfolio strategy that has come into question this year. Japanese funds cashed in on their equities portfolio after reaping a 27% return as a stimulus-fueled rally propelled global equities to a record high.The selling was possibly driven by profit taking, said Kiyoshi Ishigane, the chief fund manager at Mitsubishi UFJ Kokusai Asset Management Co. in Tokyo. Despite some progress in developing vaccines for the coronavirus, “there is still concern that the pandemic won’t come to an end anytime soon and that the world economy will have a second bottom.”The biggest monthly withdrawal in stocks during the fiscal half occurred in July when banks dumped 4.85 trillion yen worth of holdings. Trust banks’ trust accounts, often seen as proxies for pension funds, were net sellers for four months through September while they stepped up purchases of overseas debt.“Pension funds probably became overweight in overseas stocks due to higher equity prices,” said Shinichiro Kadota, Tokyo-based FX strategist at Barclays Securities Japan. “So the funds sold them and shifted to foreign bonds for passive portfolio rebalancing.”Because the shift was still within foreign assets, it wasn’t a factor for yen appreciation, he said.During this period, the S&P 500 Index and the MSCI World Index both gained about 30%. The behavior by Japanese funds may foreshadow a bigger global rebalancing shift in the last weeks of the year as stocks have continued to advance.Balanced mutual funds, which control about $7 trillion of assets, may need to sell around $160 billion of stocks to revert to their targeted 60/40 allocation, according to a JPMorgan Chase & Co. report published Nov. 20 by analysts including Nikolaos Panigirtzoglou.For Japanese investors, a steeper yield curve also helped buoy demand for the nation’s sovereign bonds this year.Yield premiums that Japan’s 30-year bonds offer over 10-year notes have more than doubled to about 60 basis points from a low of 24 basis points in March on the back of record debt-funded stimulus spending.While yield curves globally have also steepened, Japanese purchases of overseas bonds almost halved to 4.19 trillion yen in the April-September period in favor of local debt.European Bonds Are Losing a Big Fan as Japan’s Purchases PlungeJapanese funds bought 7.88 trillion yen of super-long JGBs, or almost three times the purchases of intermediate notes or more than six times the investment in long bonds, according to figures from the JSDA for the six-month period.Super-long bonds refer to debt with maturities of at least 15 years, while long bonds are notes with 10-year tenors.(Adds Japanese buying of foreign bonds in 12th paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
New images reveal how the run-down former Whiteleys shopping centre in Bayswater will be reborn as a new £1 billion residential, retail, dining and hotel complex. The 109-year-old Grade II listed mall on Queensway has been closed for two years after a period of slow decline following the opening of the nearby Westfield London mall in 2008. The building - famed for its collonaded facade and rooftop cupulas - has stood on the site since 1911 when Whiteleys was one of London’s first luxury department store.
(Bloomberg) -- Oil extended gains after closing at the highest level since August on signs Covid-19 vaccines could be rolled out within weeks and as the start of the U.S. presidential transition process aided markets in general.Futures in New York rose around 1% after settling above $43 a barrel on Monday. A vaccine developed by the University of Oxford and AstraZeneca Plc that prevented a majority of people from getting the disease could be deployed as soon as next month. That follows successful trials of two other anti-virus drugs. The triggering of a formal transition process to U.S. President-elect Joe Biden buoyed stock markets and pushed down the dollar.See also: Covid Threatens Comeback After India’s Neighbors Beat First WaveVaccine optimism has oil heading for its best month since May, with investors looking past a worsening second wave that’s spurring more lockdown measures. Covid-19 is forecast to claim another 30,000 American lives by mid-December, Japan is moving toward boosting restrictions to contain the virus and Hong Kong is set to close bars and nightclubs, according to local media.The prospect of imminent drug rollouts is reshaping the oil futures curve. Global benchmark Brent’s prompt timespread flipped into backwardation -- a bullish structure where prompt contracts are more expensive than later-dated ones -- on Monday for the first time since June. A rebound in Chinese local flights is also aiding demand for jet fuel, the hardest-hit oil product.“The AstraZeneca vaccine is really a big deal as most developed markets will be able to immunize their most at-risk population to Covid-19 by spring,” said Stephen Innes, chief market strategist at Axi. “The continuing increase in infections in the U.S. and elsewhere has been the primary source of oil demand uncertainty.”The firming of the oil futures curve is a sign the market expects a rapid tightening of supplies ahead, RBC Capital Markets analysts wrote in a report. However, the forward curve for West Texas Intermediate looks overvalued with inventories still brimming at the Cushing, Oklahoma storage hub, they said.WTI’s discount to Brent widened to the most since May amid expectations for OPEC+ to extend current output cuts into next year. Some members of the group are showing signs of strain, however. Iraq is seeking upfront payments of about $2 billion in exchange for a long-term crude-supply contract, the latest sign of Baghdad’s growing desperation for cash.Saudi Arabia, meanwhile, confirmed that Houthi rebels in Yemen targeted an oil facility in northern Jeddah province, a reminder of the ever-present risk of instability in the region. The attack on Monday caused a fire at an oil tank inside a fuel-distribution center, the kingdom’s energy ministry said.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Boris Johnson has set out new measures to stop the spread of coronavirus in England through the winter.
The College Football Playoff put out a news release to get fans ready for the season's first selection committee rankings Tuesday night. The takeaway: It's business as usual for the CFP, even if this college football season has been anything but. There is one odd pattern: The team ranked third in the committee's first rankings of the season has never made the playoff, including Alabama last year.
With less than a week to go until the big day, the giant retailer has begun its countdown with more impressive offers
These are the big savings to take advantage of, from headphones to fitness trackers
Edward Sheldon sees Amazon stock, which Warren Buffett bought last year, as a buy. But that's not the only Buffett stock he likes today. The post Amazon isn’t the only Warren Buffett stock I’d buy right now appeared first on The Motley Fool UK.
Our guide to all the latest Shark vacuum deals for Black Friday 2020, including all the top deals on Shark Navigator, VACMOP, IQ robot vacuum & more
The current pandemic has changed health sector attitudes towards the importance of recent, regularly updated real-world patient data in monitoring patient symptom trends. With more than 9 million active patients a year, THIN® is already established as one of the most relevant data sources.The Spanish data adds 2.9 million patients, 300 health institutions, and more than 4,400 GPs and specialists to the THIN® database. [24 November 2020] – Real-World Data and Real-Word Evidence provider, Cegedim Health Data, today announces the launch of its real-world Spanish data, which will enhance the European database THIN®(The Health Improvement Network). THIN® is an unobtrusive medical data collection scheme that assembles anonymised patient data from GPs and specialists. THIN® uses a common data model and aims to enable advancements in patient care and research for new treatments. Cegedim Health Data supports pharmaceutical companies, research organisations, academic institutions, and health authorities with access to over 57 million anonymised patient records across Europe. THIN® has more than 9 million active patients per year and has been cited in over 1,300 publications. As such, it is acknowledged as one of the most relevant data sources for anonymised patient data. With the Spanish data, THIN® adds 2.9 million patients — including 1 million active patients over the last 12 months — 300 health institutions and more than 4,400 GPs and specialists to its European data source, reflecting Cegedim Health Data’s ongoing commitment to enhancing the THIN® database for the benefit of patients and healthcare players. Gilles Paubert, Global Head, Cegedim Health Data, comments: “The current pandemic has highlighted the relevance of real-world patient data and has changed health sector attitudes on the importance of recent, regularly updated, real-world patient data to help monitor patient symptom trends.Whether we are providing health authorities with robust, accurate information they need to support public health decisions regarding COVID-19, or aiding over-stretched healthcare services to adapt, our aim is to help all healthcare stakeholders learn the requisite lessons for the future.” The use of quality real-world data enables a better understanding of patient profiles and pathologies, improving research, early diagnosis and treatment, in the most cost-effective way. Cegedim Health Data actively builds relationships across the healthcare ecosystem, and is a leading provider of healthcare data, leading the way in data analysis. The Cegedim Health Data team has built up expertise in structured clinical data collection since 1994, combining it with data analysis, data consulting, and more recently AI. About Cegedim Health Data: Cegedim Health Data is part of the Cegedim Group, an innovative Technology, Services and Real World Data Company that has specialised in the healthcare field for more than 50 years. Cegedim Health Data provides Real World Data and Evidence (RWD-E) to drive cutting edge improvements in patient outcomes. With a data history of over 25 years and millions of anonymised patient records immediately accessible from our THIN® (The Health Improvement Network) European database.To learn more, visit www.cegedim-health-data.com About THIN®: THIN® (The Health Improvement Network Ltd) is an unobtrusive medical data collection scheme that collects anonymised patient data from its members. Our aim is to enable advancements in patient care and outcomes by assisting leading healthcare authorities, academics and research organisations with healthcare research and analysis. To learn more, please visit: www.the-health-improvement-network.com/es About Cegedim: Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs almost 5,000 people in more than 10 countries and generated revenue in excess of €500 million in 2019. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more, please visit: www.cegedim.comAnd follow Cegedim on Twitter: @CegedimGroup, LinkedIn and Facebook. Aude BalleydierCegedimMedia Relations and Communications ManagerTel.: +33 (0)1 49 09 68 email@example.com Sandra CarnallCegedim Health Data UK Marketing Director Tel : +44 (0)7702 790381 firstname.lastname@example.org Josephine TimminsNeo PR, on behalf of Cegedim Health Data UKAccount DirectorTel : +44 (0)1296 email@example.com Attachment CegedimHealthData_THIN LAUNCH IN SPAIN_24112020_ENG
DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) DOLLY PARTON as ANGEL in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 Warning: Minor spoilers ahead for Dolly Parton’s Christmas on the Square. The holidays came early thanks to Netflix’s Christmas special Dolly Parton’s Christmas on the Square, a musical that sees the singer-actress-humanitarian as a literal angel. Following the story of Fullerville — a small town whose residents are threatened to be evicted by Regina (played by Christine Baranski), a Grinch-like character who returns home after the death of her father — Dolly Parton’s Christmas on the Square costumes feature winter-appropriate sweaters and holiday colours and prints. The film’s costume designer Provi Fulp, who calls the musical the “Fame of Christmas movies,” wanted it to feel cosy with “a little bit of Dolly charm throughout.” “There had to be some Southern charm, because Dolly is a Southern darling, and there had to be Christmas everywhere,” she says. “We peppered colours of red and green all around and added sparkle and texture and lots of knits. And especially at the finale, I just needed a Christmas explosion, and it was so easy to do it because it was a musical and I could kind of go there.” DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) JENIFER LEWIS as MARGELINE in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) SELAH KIMBRO JONES as VIOLET and MATTHEW JOHNSON as MACK in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 Throughout the film, Parton appears in over-the-top, all-white looks, ranging from crystal-adorned mini dresses to a button-down with statement buttons and frayed, crystal-encrusted jeans — all with matching 10-inch heels and jewellery, which notably includes crystal fingerless gloves and an oversized star-shaped ring. “She had some bling all the time. She’s the queen angel,” says Fulp. “She loves to shine and is so fabulous.” While Parton’s looks were designed by her longtime creative director Steve Summers, Fulp collaborated with him to make the costumes feel “all Dolly-inspired,” especially when it came to the character of Felicity (Jeanine Mason), a (secret) angel-in-training. DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) DOLLY PARTON as ANGEL in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 “When I was doing Jeanine’s character, who eventually turns into an angel, I wanted to make sure that I had some Dolly in the looks,” says Fulp. “[Before becoming an angel,] Felicity is very preppy. I wanted her to be very J. Crew-like and just really kind of appealing and warm and fuzzy.” To hint at her being more than Regina’s assistant, Fulp added a hidden touch: “Throughout you’ll notice she wears a little bit of sparkle on her neckline, she’ll have a little bit of sparkle as she goes along, and I wanted that to be some zhuzh that she has every time you see her. When she morphed into the angel, it kind of made sense that she had a little bit of Christmas and a little bit of angel in her the whole time.” DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) DOLLY PARTON as ANGEL and JEANINE MASON as FELICITY in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 In the final scene, Felicity appears in an all-white, winged angel costume featuring 1,200 Swarovski crystals and lots of tulle detailing. “I collaborated with Steven and Dolly’s team, and we made sure that it was a mirror of Dolly’s [look],” Fulp says. “When you have someone so legendary like Dolly Parton, and she’s training an angel, I was like, ‘This has to be full of fabulousness and crystals everywhere.’” DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) DOLLY PARTON as ANGEL in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 For the no-nonsense, all-business character of Regina, Fulp was inspired by the fashion of New York. “It was important for me to kind of give that Manhattan Fifth Avenue, very powerful woman kind of [look, and] sharpen it, so she’s like a butter knife just coming through,” says Fulp. With that in mind, she dressed Baranski in immaculately tailored suits and coats, from brands like Max Mara and Armani, which contrasted with the town’s more casual, soft, brightly coloured fashion. “When I read the script, it was almost like her character felt misunderstood,” she explains. “I think a lot of times as strong women, we can come across as very aggressive, because of just protecting who we are.” DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) CHRISTINE BARANSKI as REGINA and JEANINE MASON as FELICITY in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) CHRISTINE BARANSKI as REGINA and DOLLY PARTON as ANGEL in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 As Regina progresses through her character arc, her look changes, too. “I really wanted to make sure she looked really powerful and sharp and kind of cold. [She wore] very dark colours at the beginning, so that the audience can really see that she was about her business and not very warm,” Fulp points out. As Regina begins to process the painful memories associated with the town and starts to care for its residents, more colours appear in her wardrobe. “Her colours turn a little bit lighter and then go white for the finale with a dress by Alexander McQueen. She’s such a powerful character, but I used white to show the purity and the change of heart that she had, and add a little bit of Christmas spirit.” Fulp also had fun with Margeline (Jenifer Lewis), the town’s hairdresser and the only person who can stand up to Regina. In my favourite look from the film, she wears a graphic polka dot button-down, with a pair of red pants and loafers (pictured above). “I wanted to incorporate some geometric shaping and cool colour and texture. So, every time you saw her, she looked really jazzy and edgy and interesting and artistic because she’s a hairdresser,” notes Fulp. “I wanted to make sure that her bold and sassy personality showed through.” This also resulted in some standout jewellery pieces, too: “She has that big personality — she’s an artist, hair stylist, she’s got that big voice — so statement pieces were important.” DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) CHRISTINE BARANSKI as REGINA and JENIFER LEWIS as MARGELINE in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) JENIFER LEWIS as MARGELINE in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. TINA ROWDEN/NETFLIX © 2020 Fulp also paid special attention to the looks of Jenna Hathaway (Mary Lane Haskell), the pastor’s wife, taking extra care to source her looks, which included pashminas, floral skirts, and bouncy dresses. “It’s so important to me that curvy women, real women are represented. I wanted to make sure she was beautiful and sexy, but still very classy, and not frumpy. I wanted everything to be tailored to her,” says Fulp. “It was important that she’d be relatable, but also kind of unique, so that other real women could relate to her and be like, ‘I would wear that.’” DOLLY PARTON’S CHRISTMAS ON THE SQUARE (L to R) MARY LANE HASKELL as JENNA and JOSH SEGARRA as PASTOR CHRISTIAN in DOLLY PARTON’S CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 DOLLY PARTONÕS CHRISTMAS ON THE SQUARE (L to R) TREAT WILLIAMS as CARL, JOSH SEGARRA as PASTOR CHRISTIAN, MARY LANE HASKELL as JENNA, VIVIAN NIXON as BESSIE and JENIFER LEWIS as MARGELINE in DOLLY PARTONÕS CHRISTMAS ON THE SQUARE Cr. COURTESY OF NETFLIX © 2020 Like what you see? How about some more R29 goodness, right here?16 Crown Looks Inspired By Princess DianaThe Dark Significance Behind Ratched's CostumesEmily In Paris Fashion Nods To Sex And The City
British loans platform Funding Circle said on Tuesday total income rose 38% on the year in the four months to end-October and it expected second-half earnings to be materially ahead of forecasts. Loan repayments by consumers had also not been materially impacted by a second national COVID-19 lockdown, it said, although it continued to expect "a period of significant stress going forward". In the United States, total income was up 10% year on year in the four months to Oct. 30, driven by investment income, it said.
Series follows chess whizz Beth Harmon, played by Anya Taylor-Joy
Kai Havertz and Thiago Silva have both been included in Chelsea’s squad for the Champions League tie with Rennes tonight. Christian Pulisic is still recovering from a hamstring strain – but could be ready for the weekend’s top of the table showdown with Tottenham. Havertz has been out since testing positive for coronavirus before the international break.
She doesn't think husband Tom Fletcher will mind too much
Quadient Statement Paris, November 24, 2020 Following press reports issued on November 23, 2020, Quadient indicates that it has no current intention to divest its Customer Experience Management business. Quadient does receive from time to time unsolicited interests for parts of its business, which we carefully review. It is our policy not to comment publicly on any such unsolicited expressions of interest. Quadient remains fully committed to maximizing shareholder value and continues to execute its ongoing strategy. Customer Experience Management is the backbone of Quadient’s global software franchise and a key component of its strategy. Contacts Laurent Sfaxi+33 (0)1 45 36 61 firstname.lastname@example.org@quadient.com OPRG FinancialFabrice Baron+33 (0)1 53 32 61 email@example.com Attachment Company Statement_Nov24_EN
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Delivery Technologies; End User, and Geography" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US$ 95,676.62 million by2027 from US$ 58,502.18 million in 2019. The market is estimated to grow with a CAGR of 6.4% from 2020 to 2027. Based on delivery technologies, the market is segmented in to spray, nebulizers, inhalers, and others. In 2019, the inhalers segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period. An inhaler (also known as a pump, puffer, or allergy spray) is a nasal delivery device used for delivering medicines into the lungs via person's breathing mechanism. This device helps deliver medical treatment to the targeted region of the body, thereby reducing the side effects of oral medications. There are a wide variety of inhalers that are used to treat numerous medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Some of the common types of inhalers include meter-dosed inhalers, dry powder inhalers, soft mist inhalers, and others. There are certain types of inhalers containing drugs in it for the treatment of asthma and COPD such as , reliever inhalers: contain bronchodilator medicines, preventer inhalers: contain a steroid medicine. GlaxoSmithKline plc.; AstraZeneca; Pfizer Inc.; BD; Sanofi; Merck & Co.Inc.; Cadila Pharmaceuticals Ltd.; Novartis AG; Dr. Reddy's Laboratories; and Neurelis, Inc. are among the leading companies operating in the nasal delivery devices market. Key Topics Covered: 1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation2. Nasal Delivery Devices Market - Key Takeaways3. Research Methodology4. Global Nasal Delivery Devices Market - Market Landscape4.1 Overview4.2 PEST Analysis4.3 Expert Opinion5. Nasal Delivery Devices Market - Key Market Dynamics5.1 Market Drivers5.1.1 Growing Prevalence of Respiratory and CNS Diseases5.1.2 Increasing Preference and Awareness Among Patients5.2 Market Restraints5.2.1 Challenges Associated with Nasal Administration of Drugs5.3 Market Opportunities5.3.1 Rising Adoption of Self-Administration Practices5.4 Future Trends5.4.1 Consolidation of Nasal Delivery Device Industry5.5 Impact Analysis6. Nasal Delivery Devices Market - Global Analysis6.1 Global Nasal Delivery Devices Market Revenue Forecast And Analysis6.2 Global Nasal Delivery Devices Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players7. Nasal Delivery Devices Market Analysis - By Drug Type7.1 Overview7.2 Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)7.3 Anesthetics7.3.1 Overview7.3.2 Anesthetics: Nasal Delivery Devices - Revenue and Forecast to 2027 (US$ Million)7.4 Antibiotics7.5 Pain Relief Drugs7.6 Calcium Supplements7.7 Vasoconstrictors7.8 Antihistamines8. Nasal Delivery Devices Market Analysis - By Delivery Technologies8.1 Overview8.2 Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)8.3 Spray8.3.1 Overview8.3.2 Spray: Nasal Delivery Devices - Revenue and Forecast to 2027 (US$ Million)8.4 Nebulizers8.5 Inhalers9. Nasal Delivery Devices Market Analysis - By End -User9.1 Overview9.2 Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)9.3 Home Care Setting9.3.1 Overview9.3.2 Home Care Setting: Nasal Delivery Devices - Revenue and Forecast to 2027 (US$ Million)9.4 Hospitals9.5 Clinics10. Nasal Delivery Devices Market - Geographic Analysis11. Impact of COVID-19 Pandemic on Global Nasal Delivery Devices Market12. Nasal Delivery Devices Market- Industry Landscape12.1 Overview12.2 Growth Strategies Done by the Companies in the Market, (%)12.3 Organic Developments12.4 Inorganic Developments13. Company Profiles13.1 Key Facts13.2 Business Description13.3 Products and Services13.4 Financial Overview13.5 SWOT Analysis13.6 Key Developments GlaxoSmithKline plc.AstraZenecaPfizer Inc.BDSanofiMerck & Co., Inc.Cadila Pharmaceuticals Ltd.Novartis AGDr. Reddy's LaboratoriesNeurelis, Inc. For more information about this report visit https://www.researchandmarkets.com/r/v0xqp0 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Annette Guzman-Torres was feeling discouraged and frustrated, her anxiety fueled by the uncertainty of a bleak job market during the coronavirus pandemic. The 44-year-old married mother of two boys is close to finishing the capstone project for her doctorate from Capella University. “I was like, I have no job, nowhere to go, nothing to do,” said the resident of Bloomfield, New Jersey.
Boris Johnson is thrashing out plans with the devolved leaders for families to reunite over Christmas amid hopes that restrictions under the new Covid tier system will be over by Easter. Talks between the Government and Scotland, Wales and Northern Ireland are continuing in a bid to find a common approach to household mixing over the festive period. Mr Johnson confirmed on Monday that England will return to a regional tier system from December 2, but was unable to spell out any further details for Christmas.